Risk management of seasonal influenza during pregnancy: Current perspectives

International Journal of Women's Health

Volumn 6, Issue 1, 2014, Pages 681-689

  Yudin, Mark H ^a  

^a ST MICHAEL'S HOSPITAL   (Canada)

Author keywords

Antiviral medications; Knowledge; Vaccination

Indexed keywords

INFLUENZA VACCINE; OSELTAMIVIR; ZANAMIVIR;

2009 H1N1 INFLUENZA; ANTIBODY RESPONSE; ANTIBODY TITER; ANTIVIRAL THERAPY; CHEMOPROPHYLAXIS; CHILD CARE; DISEASE SEVERITY; DRUG EFFICACY; DRUG SAFETY; DRUG UPTAKE; HUMAN; IMMUNOGENICITY; INFECTION PREVENTION; INFECTION RISK; INFLUENZA VACCINATION; MATERNAL CARE; PREGNANCY; PREGNANT WOMAN; REVIEW; RISK MANAGEMENT; SEASONAL INFLUENZA; TREATMENT DURATION; TREATMENT PLANNING;

EID: 84915826541     PISSN: None     EISSN: 11791411     Source Type: Journal    
DOI: 10.2147/IJWH.S47235     Document Type: Review

References (89)

1. Harper SA, Fukuda K, Uyeki TM, Cox NJ, Bridges CB; Centers for Disease Control and Prevention (CDC) Advisory Committee on Immunization Practices (ACIP). Prevention and control of influenza: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep.2004;53(RR-6):1-40.
2. Neuzil K, Reed G, Mitchel E, Simonsen L, Griffin MR. Impact of influenza on acute cardiopulmonary hospitalizations in pregnant women. Am J Epidemiol.1998;148:1094-1102.
3. Dodds L, McNeil SA, Fell DB, et al. Impact of influenza exposure on rates of hospital admissions and physician visits because of respiratory illness among pregnant women. CMAJ.2007;176(4):463-468.
4. Schanzer DL, Langley JM, Tam TW. Influenza-attributed hospitalization rates among pregnant women in Canada1994-2000. J Obstet Gynaecol Can.2007;29:622-629.
5. Schanzer DL, Langley JM, Tam TW. Modelling the impact of influenza in Canada: a baseline for pandemic planning. Poster presented at: Second North American Congress of Epidemiology;June 23, 2006; Seattle, WA.
6. Cox S, Posner SF, McPheeters M, Jamieson DJ, Kourtis AP, Meikle S. Hospitalizations with respiratory illness among pregnant women during influenza season. Obstet Gynecol.2006;107:1315-1322.
7. Harris JW. Influenza occurring in pregnant women: a statistical study of thirteen hundred and fifty cases. JAMA.1919;72:978-980.
8. Freeman DW, Barno A. Deaths from Asian influenza associated with pregnancy. Am J Obstet Gynecol.1959;78:1172-1175.
9. Mosby LG, Rasmussen SA, Jamieson DJ.2009 pandemic influenza A (H1N1) in pregnancy: a systematic review of the literature. Am J Obstet Gynecol.2011;205:10-18.
10. Campbell A, Rodin R, Kropp R, et al. Risk of severe outcomes among patients admitted to hospital with pandemic (H1N1) influenza. CMAJ. 2010;182(4):349-355.
11. Oluyomi-Obi T, Avery L, Schneider C, et al. Perinatal and maternal outcomes in critically ill obstetrics patients with pandemic H1N1 influenza A. J Obstet Gynaecol Can.2010;32(5):443-447.
12. Rolland-Harris E, Vachon J, Kropp R, et al. Hospitalization of pregnant women with pandemic A(H1N1)2009 influenza in Canada. Epidemiol Infect.2012;140:1316-1327.
13. Siston AM, Rasmussen SA, Honein MA, et al. Pandemic2009 influenza A (H1N1) virus illness among pregnant women in the United States. JAMA.2010;303:1517-1525.
14. Centers for Disease Control and Prevention (CDC). Novel influenza A (H1N1) virus infections in three pregnant women-United States, April-May2009. MMWR Morb Mortal Wkly Rep.2009;58(18): 497-500.
15. Jamieson DJ, Honein MA, Rasmussen SA, et al. H1N12009 influenza virus infection during pregnancy in the USA. Lancet.2009;374: 451-458.
16. Creanga AA, Johnson TF, Graitcer SB, et al. Severity of2009 pandemic influenza A (H1N1) virus infection in pregnant women. Obstet Gynecol. 2010;115(4):717-726.
17. Louie JK, Acosta M, Jamieson DJ, Honein MA. Severe2009 H1N1 influenza in pregnant and postpartum women in California. N Engl J Med.2010;362(1):27-35.
18. Hewagama S, Walker SP, Stuart RL, et al.2009 H1N1 influenza A and pregnancy outcomes in Victoria, Australia. Clin Infect Dis. 2010;50:686-690.
19. Zou S. Potential impact of pandemic influenza on blood safety and availability. Transfus Med Rev.2006;20:181-189.
20. Irving WL, James DK, Stephenson T, et al. Influenza virus infection in the second and third trimesters of pregnancy: a clinical and seroepidemiological study. BJOG.2000;107:1282-1289.
21. McNeil SA, Dodds LA, Fell DB, et al. Effect of respiratory hospitalization during pregnancy on infant outcomes. Am J Obstet Gynecol. 2011;204(Suppl):S54-S57.
22. Bloom-Feshbach K, Simonsen L, Viboud C, et al. Natality decline and miscarriages associated with the1918 influenza pandemic: the Scandinavian and United States experiences. J Infect Dis.2011;204:1157-1164.
23. Haberg SE, Trogstad L, Gunnes N, et al. Risk of fetal death after pandemic influenza virus infection or vaccination. N Engl J Med. 2013;368(4):333-340.
24. Pierce M, Kurinczuk JJ, Spark P, Brocklehurst P, Knight M. Perinatal outcomes after maternal2009/H1N1 infection: national cohort study. BMJ.2011;342:d3214.
25. Centers for Disease Control and Prevention (CDC). Maternal and infant outcomes among serverely ill pregnant and postpartum women with 2009 pandemic influenza A (H1N1)-United States, April2009-August 2010. MMWR Morb Mortal Wkly Rep.2011;60:1193-1196.
26. Yates L, Pierce M, Stephens S, et al. Influenza A/H1N1v in pregnancy: an investigation of the characteristics and management of affected women and the relationship to pregnancy outcomes for mother and infant. Health Technol Assess.2010;14:109-182.
27. Mendez-Figueroa H, Raker C, Anderson BL. Neonatal characteristics and outcomes of pregnancies complicated by influenza infection during the 2009 pandemic. Am J Obstet Gynecol.2011;204(Suppl):S58-S63.
28. Public Health Agency of Canada. National Advisory Committee on Immunization (NACI) statement on seasonal influenza vaccination for 2013-2014. CCDR.2013;39(ACS-4):1-39.
29. Murray DL, Imagawa DT, Okada DM, St Geme JW Jr. Antibody response to monovalent A/New Jersy/8/76 influenza vaccine in pregnant women. J Clin Microbiol.1979;10:184-187.
30. Sumaya CV, Gibbs RS. Immunization of pregnant women with influenza A/New Jersey/76 virus vaccine: reactogenicity and immunogenicity in mother and infant. J Infect Dis.1979;140:141-146.
31. Englund JA, Mbawuike IN, Hammil H, Holleman MC, Baxter BC, Glezen WP. Maternal immunization with influenza or tetanus toxoid vaccine for passive antibody protection in young infants. J Infect Dis. 1993;168:647-656.
32. Steinhoff MC, Omer SB, Roy E, et al. Influenza immunization in pregnancy-antibody responses in mothers and infants. N Engl J Med. 2010;362:1644-1646.
33. Tsatsaris V, Capitant C, Schmitz T, et al. Maternal immune response and neonatal seroprotection from a single dose of a monovalent nonadjuvanted2009 influenza A(H1N1) vaccine: a single-group trial. Ann Intern Med.2011;155:733-741.
34. Fisher BM, Van BJ, Hart J, et al. Pandemic influenza A H1N12009 infection versus vaccination: a cohort study comparing immune responses in pregnancy. PLoS One.2021;7:e33048.
35. Schlaudecker EP, McNeal MM, Dodd CN, Ranz JB, Steinhoff MC. Pregnancy modifies the antibody response to trivalent influenza immunization. J Infect Dis.2012;206:1670-1673.
36. Sperling RS, Engel SM, Wallenstein S, et al. Immunogenicity of trivalent inactivated influenza vaccination received during pregnancy or postpartum. Obstet Gynecol.2012;119(3):631-639.
37. Zaman K, Roy E, Arifeen SE, et al. Effectiveness of maternal influenza immunization in mothers and infants. N Engl J Med.2008;359: 1555-1564.
38. Thompson MG, Li D, Shifflett P, et al. Effectiveness of seasonal trivalent influenza vaccine for preventing influenza virus illness among pregnant women: a population-based case-control study during the2010-2011 and2011-2012 influenza seasons. Clin Infect Dis.2014;58:449-457.
39. Eick AA, Uyeki TM, Klimov A, et al. Maternal influenza vaccination and effect on influenza virus infection in young infants. Arch Pediatr Adolesc Med.2011;165(2):104-111.
40. Benowitz I, Esposito DB, Gracey KD, Shapiro ED, Vázquez M. Influenza vaccine given to pregnant women reduces hospitalization due to influenza in their infants. Clin Infect Dis.2010;51:1355-1361.
41. Poehling KA, Szilagyi PG, Staat MA, et al. Impact of maternal immunization on influenza hospitalizations in infants. Am J Obstet Gynecol. 2011;204:S141-S148.
42. Dodds L, MacDonald N, Scott J, Spencer A, Allen VM, McNeil S. The association between influenza vaccine in pregnancy and adverse neonatal outcomes. J Obstet Gynaecol Can.2012;34(8):714-720.
43. Steinhoff MC, Omer SB, Roy E, et al. Neonatal outcomes after influenza immunization during pregnancy: a randomized controlled trial. CMAJ. 2012;184:645-653.
44. Omer SB, Goodman D, Steinhoff MC, et al. Maternal influenza immunization and reduced likelihood of prematurity and small for gestational age births: a retrospective cohort study. PLoS Med.2011;8:e1000441.
45. Jackson LA, Patel SM, Swamy GK, et al. Immunogenicity of an inactivated monovalent2009 H1N1 influenza vaccine in pregnant women. J Infect Dis.2011;204:854-863.
46. Abzug MJ, Nachman SA, Muresan P, et al. Safety and immunogenicity of2009 pH1N1 vaccination in HIV-infected pregnant women. Clin Infect Dis.2013;56:1488-1497.
47. Richards JL, Hansen C, Bredfeldt C, et al. Neonatal outcomes after antenatal influenza immunization during the2009 H1N1 influenza pandemic: impact on preterm birth, birth weight, and small for gestational age. Clin Infect Dis.2013;56:1216-1222.
48. Fell DB, Sprague AE, Liu N, et al. H1N1 influenza vaccination during pregnancy and fetal and neonatal outcomes. Am J Public Health. 2012;102:e33-e40.
49. Heinonen OP, Shapiro S, Monson RR, Hartz SC, Rosenberg L, Slone D. Immunization during pregnancy against poliomyelitis and influenza in relation to childhood malignancy. Int J Epidemiol.1973;2:229-235.
50. Black SB, Shinefield HR, France EK, Fireman BH, Platt ST, Shay D. Effectiveness of influenza vaccine during pregnancy in preventing hospitalizations and outpatient visits for respiratory illness in pregnant women and their infants. Am J Perinatol.2004;21:333-339.
51. Pool V, Iskander J. Safety of influenza vaccination during pregnancy. Am J Obstet Gynecol.2006;194:1200.
52. Moro PL, Broder K, Zheteyeva Y, et al. Adverse events in pregnant women following administration of trivalent inactivated vaccine and live attenuated influenza vaccine in the Vaccine Adverse Event Reporting System,1990-2009. Am J Obstet Gynecol.2010;204:146. e1-e7.
53. Zuccotti G, Pogliani L, Pariani E, Amendola A, Zanetti A. Transplacental antibody transfer following maternal immunization with a pandemic2009 influenza A (H1N1) MF59-adjuvanted vaccine. JAMA.2010;304:2360-2361.
54. Omon E, Damase-Michel C, Hurault-Delarue C, et al. Non-adjuvanted 2009 influenza A(H1N1) vaccine in pregnant women: the results of a French prospective descriptive study. Vaccine.2011;29:9649-9654.
55. Mackenzie IS, Macdonald TM, Shakir S, et al. Influenza H1N1 (swine flu) vaccination: a safety surveillance feasibility study using selfreporting of serious adverse events and pregnancy outcomes. Br J Clin Pharmacol.2012;73:801-811.
56. Tavares F, Nazareth I, Monegal JS, Kolte I, Verstraeten T, Bauchau V. Pregnancy and safety outcomes in women vaccinated with an AS03-adjuvanted split virion H1N1 (2009) pandemic influenza vaccine during pregnancy: a prospective cohort study. Vaccine.2011;29: 6358-6365.
57. Moro PL, Broder K, Zheyeyeva Y, et al. Adverse events following administration to pregnant women of influenza A (H1N1)2009 monovalent vaccine reported to the Vaccine Adverse Event Reporting System. Am J Obstet Gynecol.2011;205:473. e1-e9.
58. Herberts C, Melgert B, Van Der Laan JW, Faas M. New adjuvanted vaccines in pregnancy: what is known about their safety? Expert Rev Vaccines.2010;9:1411-1422.
59. Heikkinen T, Young J, van Beek E, et al. Safety of MF59-adjuvanted A/H1N1 influenza vaccine in pregnancy: a comparative cohort study. Am J Obstet Gynecol.2012;207:177. e1-e8.
60. Gonik B, Jones T, Contreras D, Fasano N, Roberts C. The obstetriciangynecologist's role in vaccine-preventablediseases and immunization. Obstet Gynecol.2000;96:81-84.
61. Centers for Disease Control and Prevention (CDC). Influenza vaccination in pregnancy: practices among obstetrician-gynecologists-United States,2003-04 influenza season. MMWR Morb Mortal Wkly Rep. 2005;54(41):1050-1052.
62. Yudin MH, Salaripour M, Sgro MD. Pregnant women's knowledge of influenza and the use and safety of the influenza vaccine during pregnancy. J Obstet Gynaecol Can.2009;31(2):120-125.
63. SteelFisher GK, Blendon RJ, Bekheit MM, et al. Novel pandemic A (H1N1) influenza vaccination among pregnant women: motivators and barriers. Am J Obstet Gynecol.2011;204(6 Suppl1):S116-S123.
64. Fisher BM, Scott J, Hart J, Winn VD, Gibbs RS, Lynch AM. Behaviors and perceptions regarding seasonal and H1N1 influenza vaccination during pregnancy. Am J Obstet Gynecol.2011;204(6 Suppl1): S107-S111.
65. Goldfarb I, Panda B, Wylie B, Riley L. Uptake of influenza vaccine in pregnant women during the2009 H1N1 influenza pandemic. Am J Obstet Gynecol.2011;204(6 Suppl1):S112-S115.
66. Centers for Disease Control and Prevention (CDC). Seasonal influenza and2009 H1N1 influenza vaccination coverage among pregnant women-10 states,2009-10 influenza season. MMWR Morb Mortal Wkly Rep.2010;59(47):1541-1545.
67. Centers for Disease Control and Prevention (CDC). Influenza vaccination coverage among pregnant women: United States,2010-11 influenza season. MMWR Morb Mortal Wkly Rep.2011;60:1078-1082.
68. Tong A, Biringer A, Ofner-Agostini M, Upshur R, McGeer A. A cross-sectional study of maternity care providers' and women's knowledge, attitudes, and behaviours towards influenza vaccination during pregnancy. J Obstet Gynaecol Can.2008;30(5):404-410.
69. Schrag SJ, Fiore AE, Gonik B, et al. Vaccination and perinatal infection prevention practices among obstetrician-gynecologists. Obstet Gynecol. 2003;101:704-710.
70. Broughton DE, Beigi RH, Switzer GE, Raker CA, Anderson BL. Obstetric health care workers' attitudes and beliefs regarding influenza vaccination in pregnancy. Obstet Gynecol.2009;114:981-987.
71. Dlugacz Y, Fleischer A, Torroella Carney M, et al.2009 H1N1 vaccination by pregnant women during the2009-10 H1N1 influenza pandemic. Am J Obstet Gynecol.2012;206:339. e1-e8.
72. Ahluwalia IB, Jamieson DJ, Rasmussen SA, D'Angelo D, Goodman D, Kim H. Correlates of seasonal influenza vaccine coverage among pregnant women in Georgia and Rhode Island. Obstet Gynecol.2010;116: 949-955.
73. Tucker Edmonds BM, Coleman J, Armstrong K, Shea JA. Risk perceptions, worry, or distrust: what drives pregnant women's decisions to accept the H1N1 vaccine? Matern Child Health J.2011;15: 1203-1209.
74. Fridman D, Steinberg E, Azhar E, Weedon J, Wilson TE, Minkoff H. Predictors of H1N1 vaccination in pregnancy. Am J Obstet Gynecol. 2011;204(6 Suppl1):S124-S127.
75. Henninger M, Naleway A, Crane B, Donahue J, Irving S. Predictors of seasonal influenza vaccination during pregnancy. Obstet Gynecol. 2013;121:741-749.
76. Yudin MH, Salaripour M, Sgro MD. Impact of patient education on knowledge of influenza and vaccine recommendations among pregnant women. J Obstet Gynaecol Can.2010;32(3):232-237.
77. Moniz MH, Hasley S, Meyn LA, Beigi RH. Improving influenza vaccination rates in pregnancy through text messaging: a randomized controlled trial. Obstet Gynecol.2013;121:734-740.
78. Aoki FY, Allen UD, Stiver HG, Evans GA. The use of antiviral drugs for influenza: guidance for practitioners2012/2013. J Infect Dis Med Microbiol.2012;23(4):e79-e92.
79. Influenza antiviral medications: summary for clinicians (webpage on the Internet). Atlanta: Centers for Disease Control and Prevention; 2012. Available from: http://www.cdc.gov/flu/professionals/antivirals/ summary-clinicians.htm. Accessed February9,2014.
80. Jefferson T, Jones M, Dosho P, et al. Neuraminidase inhibitors for preventing and treating influenza in healthy adults: systematic review and meta-analysis. BMJ.2009;339:b5106.
81. Matheson NJ, Hamden AR, Perera R, Sheikh A, Symmonds-Abrahams M. Neuraminidase inhibitors for preventing and treating influenza in children. Cochrane Database Syst Rev.2007;(1):CD002744.
82. Falagas ME, Koletsi PK, Voulourmanon EK, et al. Effectiveness and safety of neuraminidase inhibitors in reducing influenza complications: a meta-analysis of randomized controlled trials. J Antimicrob Chemother.2010;65:1330-1346.
83. Greer LG, Leff RD, Rogers VL, et al. Pharmacokinetics of oseltamivir according to trimester of pregnancy. Am J Obstet Gynecol.2011; 204(6 Suppl1):S89-S93.
84. Beigi RH, Han K, Venkataramanan R, et al. Pharmacokinetics of oseltamivir among pregnant and nonpregnant women. Am J Obstet Gynecol. 2011;204(6 Suppl1):S84-S88.
85. Tanaka T, Nakajima K, Murashima A, Garcia-Bournissen F, Koren G, Ito S. Safety of neuraminidase inhibitors against novel influenza A (H1N1) in pregnant and breastfeeding women. CMAJ.2009;181(1-2):55-58.
86. Svensson T, Granath F, Stephansson O, Kieler H. Birth outcomes among women exposed to neuraminidase inhibitors. Pharmacoepidemiol Drug Saf.2011;20:1030-1034.
87. Greer LG, Sheffield JS, Rogers VL, Roberts SW, McIntire DD, Wendel GD. Maternal and neonatal outcomes after antepartum treatment of influenza with antiviral medications. Obstet Gynecol.2010;115(4):711-716.
88. Saito S, Minakami H, Nakai A, Unno N, Kubo T, Yoshimura Y. Outcomes of infants exposed to oseltamivir or zanamivir in utero during pandemic (H1N1)2009. Am J Obstet Gynecol.2013;209:130. e1-e9.
89. Xie H, Yasseen AS3rd, Xie RH, et al. Infant outcomes among pregnant women who used oseltamivir for treatment of influenza during the H1N1 epidemic. Am J Obstet Gynecol.2013;208:293. e1-e7.